Navigation Links
New Research Confirms Bonicel's Multiple Anti-Aging Benefits

CLEVELAND, OH (PRWEB) February 05, 2013

Ganeden Biotech announces impressive results from its third study on its beauty ingredient Bonicel.

Supporting the previous study results on Ganeden’s patented probiotic (beneficial bacteria) derived, cosmeceutical ingredient, Bonicel once again improved skin hydration, elasticity, under eye puffiness and reduced fine lines and wrinkles in humans and even reduced redness.

"We are thrilled that once again, a third-party, placebo controlled study demonstrates that Bonicel is so effective as a combination anti-aging beauty ingredient. Not only does it moisturize and increase skin elasticity, it also reduces fine lines and wrinkles; it's impressive that one ingredient can do all that,” said David Keller, Vice President, Scientific Operations, Ganeden Biotech.

This is good news for beauty manufacturers looking for natural, science-backed ingredients to launch products in this $60 billion dollar U.S. industry that experienced double digit growth last year.

“We are seeing a lot of introductions in ‘probiotic’ topical skin care products, but few, if any, have research demonstrating they work at time of application. We’re excited that we have science showing that Bonicel does,” Keller said.

Bonicel also meets the strict standards of the burgeoning natural and organic personal care industry such as non-GMO, gluten-free and natural. The $9 billion natural and organic personal care category is experiencing consistent year-over-year growth.

Bonicel can be used in lotions, creams, gels, powders, scrubs, masks and cleansers. Unlike most probiotic ingredients used in topical formulations, including Lactobacillus and Bifidobacterium, Bonicel, naturally derived from the well-documented probiotic strain GanedenBC30® (Bacillus coagulans GBI-30, 6086), is easy to include in formulations.

Bonicel is produced naturally during the fermentation process of GanedenBC30, the company’s proprietary probiotic strain. Ganeden utilizes proprietary processes to optimize the metabolic activity of the fermenting organism producing maximum levels of the organism’s metabolites.

Photos from the research, which show the drastic wrinkle reduction, are available upon request.

About Ganeden Biotech
Founded in 1997 the Cleveland, Ohio-based Ganeden Biotech is at the forefront of probiotic research and product development with an extensive library of published studies and more than 100 patents for probiotic technologies for the food, beverage, animal health, and now topical ingredients markets. Ganeden is best known for GanedenBC30® (Bacillus coagulans GBI-30, 6086), its patented, FDA GRAS probiotic ingredient found in more than 60 leading food and beverage products. A highly stable probiotic ingredient with physical properties that make it more stable than traditional probiotic organisms (such as Lactobacillus and Bifidobacterium); GanedenBC30 is ideally suited for almost any food, beverage or animal health application. Ganeden's newest ingredient, Bonicel, is a patented, probiotic-derived, topical cosmeceutical ingredient shown to dramatically reduce signs of aging. It can easily be incorporated in virtually any lotion, cream, soap, shampoo or other personal care product.

Ganeden Biotech takes special care to help manufacturers develop and market probiotic products. For more information about Ganeden Biotech and licensing opportunities visit

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Cutting the Cost of Clinical Research: The Solution Comes from Russia, New Xtalks Webinar
2. Human Research Protection and Understanding the Landscape of AAHRPP Accreditation
3. TNI BioTech Acquires Exclusive License To The Portfilio Of Patents Of Dr Ian S. Zagon, Dr. Patricia J. McLauglin And Dr. Jill Smith From The Penn State Research Foundation
4. Free Research Report on Dyax Corp., Ebix, Inc., 8x8, Inc., EnerSys and Express Scripts Holding Co.
5. Elsevier and Kanazawa University in Japan Collaborate to Map Universitys Research Performance
6. New semiconductor research may extend integrated circuit battery life tenfold
7. NTU research embraces laser and sparks cool affair
8. Penn research shows mechanism behind wear at the atomic scale
9. Inflamax Research Introduces Electronic Patient Data Acquisition Tablet™ (ePDAT)™ for Real-Time PRO Data Collection
10. Salimetrics to Present Workshop on the Integration of Salivary Analytes into Scientific Studies at the Society for Research in Child Development (SRCD) Preconference
11. Tracking the Battle Against Breast Cancer With New Market Research
Post Your Comments:
(Date:11/30/2015)... (PRWEB) , ... November 30, ... ... Company, today announced tighter software integration with MarkLogic, the Enterprise NoSQL database ... maximize information to drive change. , Smartlogic’s Content Intelligence capabilities provide a ...
(Date:11/27/2015)... /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ), a ... closed the sale of its global contrast media and ... in a transaction valued at approximately $270 million. The ... total of approximately 1,000 employees spread across the globe, ... area. This entire workforce and the manufacturing ...
(Date:11/26/2015)... November 26, 2015 ... Accutest Research Laboratories, a leading ... Organization (CRO), has formed a strategic ... - Temple Health for joint work ... (Photo: ) , --> ...
(Date:11/25/2015)... ANNAPOLIS, Md. , Nov. 25, 2015  PharmAthene, ... of Directors has adopted a stockholder rights plan (Rights ... its net operating loss carryforwards (NOLs) under Section 382 ... --> --> PharmAthene,s use of its ... an "ownership change" as defined in Section 382 of ...
Breaking Biology Technology:
(Date:11/12/2015)... , Nov. 12, 2015  Arxspan has entered ... MIT and Harvard for use of its ArxLab ... management tools. The partnership will support the institute,s ... and chemical research information internally and with external ... used for managing the Institute,s electronic laboratory notebook, ...
(Date:11/10/2015)... 2015  In this report, the biomarkers ... product, type, application, disease indication, and geography. ... are consumables, services, software. The type segments ... efficacy biomarkers, and validation biomarkers. The applications ... development, drug discovery and development, personalized medicine, ...
(Date:11/9/2015)...  Synaptics Inc. (NASDAQ: SYNA ), the leading ... into the automotive market with a comprehensive and dedicated ... consumer electronics human interface innovation. Synaptics, industry-leading touch controllers, ... automotive industry and will be implemented in numerous locations ... , Japan , and ...
Breaking Biology News(10 mins):